USA Rice Federation today filed comments with the U.S. Department of Agriculture’s Animal Plant Health Inspection service (APHIS) asking ”in the strongest possible terms that the permit for Ventria [Bioscience]’s pharmaceutical rice be denied.” Ventria is seeking USDA approval for growing non-food rice bioengineered to contain the human proteins lysozyme, lactoferrin and recombinant human serum albumin.